CpG oligodeoxynucleotide-enhanced humoral immune response and production of antibodies to prion protein PrPSc in mice immunized with 139A scrapie-associated fibrils

Autor: Jae I. I. Kim, William R. Levis, Xuemin Ye, Daryl S. Spinner, Georgia Schuller-Levis, Richard J. Kascsak, Thomas Wisniewski, Michael Flory, Giuseppe LaFauci, Richard I. Carp, Harry C. Meeker, Regina Kascsak
Rok vydání: 2007
Předmět:
Zdroj: Journal of Leukocyte Biology. 81:1374-1385
ISSN: 1938-3673
0741-5400
DOI: 10.1189/jlb.1106665
Popis: Prion diseases are characterized by conversion of the cellular prion protein (PrP C )t o a protease-resistant conformer, the srapie form of PrP (PrP Sc ). Humoral immune responses to non- denatured forms of PrP Sc have never been fully characterized. We investigated whether produc- tion of antibodies to PrP Sc could occur in PrP null (Prnp / ) mice and further, whether innate im- mune stimulation with the TLR9 agonist CpG oli- godeoxynucleotide (ODN) 1826 could enhance this process. Whether such stimulation could raise anti-PrP Sc antibody levels in wild-type (Prnp / ) mice was also investigated. Prnp / and Prnp / mice were immunized with nondenatured 139A scrapie-associated fibrils (SAF), with or without ODN 1826, and were tested for titers of PrP- specific antibodies. In Prnp / mice, inclusion of ODN 1826 in the immunization regime increased anti-PrP titers more than 13-fold after two immu- nizations and induced, among others, antibodies to an N-terminal epitope, which were only present in the immune repertoire of mice receiving ODN 1826. mAb 6D11, derived from such a mouse, reacts with the N-terminal epitope QWNK in native and denatured forms of PrP Sc and recombinant PrP and exhibits a Kd in the 10 11 M range. In Prnp / mice, ODN 1826 increased anti-PrP lev- els as much as 84% after a single immunization. Thus, ODN 1826 potentiates adaptive immune re- sponses to PrP Sc in 139A SAF-immunized mice. These results represent the first characterization of humoral immune responses to nondenatured, in- fectious PrP Sc and suggest methods for optimizing the generation of mAbs to PrP Sc , many of which could be used for diagnosis and treatment of prion diseases. J. Leukoc. Biol. 81: 1374-1385; 2007.
Databáze: OpenAIRE